1007876-49-4

Basic information

• Product Name: C₂₆H₃₄N₂O₅S
• Synonyms: C₂₆H₃₄N₂O₅S
• CAS NO: 1007876-49-4
• Molecular Weight: 486.632
• Mol File: 1007876-49-4.mol

Chemical Properties

• CAS DataBase Reference: C₂₆H₃₄N₂O₅S(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₆H₃₄N₂O₅S(1007876-49-4)
• EPA Substance Registry System: C₂₆H₃₄N₂O₅S(1007876-49-4)

Safety Data

• Hazardous Substances Data: 1007876-49-4(Hazardous Substances Data)

Upstream product

• 141403-49-8 (2S)-2-[N-(tert-butoxycarbonyl)amino]-3-phenyl-O-(4-methylphenylsulfonyl)propan-1-ol 
• 134557-74-7 tert-butyl [(2S)-1-azido-3-phenylpropan-2-yl]carbamate 
• 146552-72-9 (S)-2-(t-butoxycarbonylamino)-3-phenylpropylamine 
• 66605-57-0 (S)-N-tert-butoxycarbonyl-2-amino-3-phenylpropanol 
• 869885-60-9 1-benzofuran-5-sulfonyl chloride 
• 1007877-59-9 C₁₈H₃₀N₂O₂ 

Relevant articles and documents

METHODS FOR INHIBITING DRUG DEGRADATION

Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450. Pharmaceutical compositions are provided that can act as boosters

HIV PROTEASE INHIBITOR AND CYTOCHROME P450 INHIBITOR COMBINATIONS

Compositions and methods of treating viral infections are provided. More particularly, compositions including a combination of protease inhibitors and cytochrome p450 enzyme inhibitors are provided. Methods of using the compositions for treatment of disea

COMPOSITIONS AND METHODS FOR INHIBITING CYTOCHROME P450

Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450. Pharmaceutical compositions are provided that can act as boosters